avatar

DR. MOHAMAD SHAFIQ BIN AZANAN

Department of Paediatrics

Faculty of Medicine

mohamadshafiq@um.edu.my
View CV
Publons
Scopus Link
Biography

Dr Mohamad Shafiq is a Senior Lecturer at the Department of Paediatrics, Faculty of Medicine, Universiti Malaya. He holds a Bachelor of Science degree, majoring in Biotechnology, specializing in cellular, molecular, and developmental biology, from the University of Melbourne, Australia. He completed his Honours Year for a project on skeletal developmental disease at the Murdoch Children's Research Institute and the Royal Children Hospital, Melbourne. He then obtained his Ph.D. from Universiti Malaya in 2019 for his research on the role of immune derangements in the late effects of childhood cancer survivors. Currently his research topics involved haematology-oncology, ageing and paediatric research. He is also the consultants and collaborates in many projects that involved flow cytometry.


Close
Collaborator
View all collaborators
Statistics
Annual Publications by Category
Summary of Budget vs Expenditure per vote for all research grants
Last 3 Projects
Project Title Progress Status
Mitigation Of Accelerated Immunologic Ageing In Childhood Cancer Survivors By Increasing Nicotinamide Adenine Dinucleotide (NAD+) Bioavailability For Sirtuin 1 Through CD38 Catalytic Inhibition
on going
Improving Survival Quality Of Childhood Cancer Via Lifestyle Modifications
end
This information is generated from Research Grant Management System
Latest Publication
View All  
2024

Effectiveness of education intervention, with regards to physical activity level and a healthy diet, among Middle Eastern adolescents in Malaysia: A study protocol for a randomized control trial, based on a health belief model

2023

Poor sleep quality in children with atopic dermatitis and its effects on behavior: A multicenter cross-sectional study from a low-middle-income country

2023

Physical Inactivity as an Early Sign of Frailty in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia

2023

Manipulating the Gut Microbiome as a Therapeutic Strategy to Mitigate Late Effects in Childhood Cancer Survivors